The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.
 
Denis Moro-Sibilot
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly/ImClone; Novartis; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Lilly/ImClone; Pfizer; Roche/Genentech
 
Laura Faivre
No Relationships to Disclose
 
Gerard Zalcman
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Maurice Pérol
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Fabrice Barlesi
Honoraria - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Genentech/Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Lilly; Novartis; Novartis
 
Josiane Otto
No Relationships to Disclose
 
Isabelle Monnet
No Relationships to Disclose
 
Alexis B. Cortot
Honoraria - AstraZeneca; Boehringer Ingelheim
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Expert Testimony - Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline; Lilly
 
Marie Wislez
Honoraria - AstraZeneca
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Hervé Lena
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Pfizer; Roche Pharma AG
 
Julien Mazières
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Research Funding - Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Xavier Durando
No Relationships to Disclose
 
Sylvie Lantuejoul
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Pfizer
 
Isabelle Rouquette
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche Pharma AG
 
Anne McLeer Florin
Consulting or Advisory Role - Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Pfizer; Roche Pharma AG
 
Gilbert Ferretti
No Relationships to Disclose
 
Natalie Hoog Labouret
Employment - Amgen (I)
Leadership - Amgen (I)
Stock and Other Ownership Interests - Amgen (I)
 
Frederique Nowak
No Relationships to Disclose
 
Marta Jimenez
No Relationships to Disclose
 
Gilles Vassal
No Relationships to Disclose